KEL*02N.19Kell-null,KEL*02,Ku

Ravi C Dara1, Rania Madkour1, Kathleen Bensing2

  • 1Laboratory Department -Transfusion Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.

Vox sanguinis
|February 15, 2026
PubMed
概括

识别罕见的凯尔血型抗体,如抗Ku,对于复杂癌症患者的输血管理至关重要. 这个案例突出了成功的非输血治疗的综合血清学和分子方法.